Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


13th World Congress on Healthcare & Technologies

Dublin, Ireland

David Sergio Salas Vargas

David Sergio Salas Vargas

Universidad Autónoma de Baja California, Mexico

Title: Risk factors for nonadherence to treatment, and complications in patients with Type 2 diabetes attending a primary care health center in ensenada, México


Biography: David Sergio Salas Vargas


Background: Type 2 diabetes mellitus (T2DM) has a high prevalence in the northern region of Mexico (15.7%). It represents one of the greatest burdens for the Mexican healthcare system. Approximately 75% of patients with T2DM have not reached adequate glycemic control.

Methods: This is a descriptive, cross-sectional study in a convenience sample of 184 T2DM patients attending a primary health care center in Ensenada, Baja California from 2010 to 2012. A structured survey was applied to determine risk factors for non-adherence to treatment, comorbidities and complications of patients with T2DM.

Results: 64% were women average age 58 years. 10% were illiterate and 25% with unfinished elementary school; 22% were active smokers, 77% with a sedentary life and 60% consumes sugary drinks; 42% reported difficult access to the health center due to long distance and expensive bus transportation. The majority (84%) had to buy their medicines. Only 42% carried out the control laboratory exams requested. Nearly 70% had high blood pressure and 44% were not controlled; 46% had dyslipidemia and 68% were obese. Almost 2% of the patients developed retinopathy and/or neuropathy and /or diabetic foot.

Conclusions: It is necessary to develop a more efficient monitoring and control program for patients with T2DM, to reduce comorbidities and complications through reducing risk factors that favors the non-adherence to pharmacological treatment, such as the lack of access to healthcare centers, the need to buy their medicines, and the lack of metabolic control among others